Fact CheckerSign in

NCT04881656Active, not recruiting

Evaluating the Impact of Telehealth-Based ASD Assessments and Supports on Child and Caregiver Outcomes

Evaluating the Impact of Telehealth-Based Autism Spectrum Disorder Assessments and Supports on Child and Caregiver Outcomes

Source: ClinicalTrials.gov · Last updated 13 Oct 2026

Brief summary (registry, in English)

The overall goal of this study is to evaluate telehealth and internet-based approaches to meet accessibility challenges for families with concerns about ASD in their infants. In this study, we will gather exploratory data related to the potential of two telehealth tools: 1) The Telehealth Evaluation of Development for Infants (TEDI); and 2) "Help is in Your Hands" (HIIYH), a set of video materials and information on interactive strategies parents can use to support their child's communication development. We will recruit families participating in an ongoing study using the TEDI (R21 HD100372, PI: Talbott) to evaluate infants' behavioral development. As families exit the parent TEDI study and enter the current study, we will ask parents to complete online questionnaires, and randomize them to either receive immediate access to additional online materials (HIIYH) for parents or no additional materials. After 12 weeks, parents will complete online questionnaires and all families will then be given access to the online materials. When children reach 30 months, we will collect additional questionnaires, complete a live telehealth behavioral session with toddlers and their caregivers, and conduct an exit interview with parents to gather feedback about their experience.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
80 (estimated)
First submitted
6 May 2021
Start date
1 Sept 2021
Primary completion date
31 May 2033
Lead sponsor
University of California, Davis
Diseases
Autism
NCT number
NCT04881656

What you commit to

  • Study type: Interventional
  • Planned participants: 80
  • From 1 Sept 2021 to the primary completion date, 31 May 2033
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • No previous enrollment in the parent R21 project (R21 HD100372, PI: Talbott).

Who the study is looking for

  • Previous enrollment in the parent R21 project (R21 HD100372, PI: Talbott).

Age in the registry: 6 months to 99 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of California Davis Health
Coordinator of this site? Confirm its status
SacramentoUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.